Acotec Scientific Holdings (HKSE:06669) Gross Margin % : 78.99% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Acotec Scientific Holdings's Gross Profit for the six months ended in Dec. 2023 was HK$199.4 Mil. Acotec Scientific Holdings's Revenue for the six months ended in Dec. 2023 was HK$252.4 Mil. Therefore, Acotec Scientific Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 78.99%.

The historical rank and industry rank for Acotec Scientific Holdings's Gross Margin % or its related term are showing as below:

HKSE:06669' s Gross Margin % Range Over the Past 10 Years
Min: 79.65 Med: 84.81 Max: 87.53
Current: 79.65

During the past 5 years, the highest Gross Margin % of Acotec Scientific Holdings was 87.53%. The lowest was 79.65%. And the median was 84.81%.

HKSE:06669's Gross Margin % is ranked better than
89.64% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.83 vs HKSE:06669: 79.65

Acotec Scientific Holdings had a gross margin of 78.99% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Acotec Scientific Holdings was 0.00% per year.

Acotec Scientific Holdings Gross Margin % Historical Data

The historical data trend for Acotec Scientific Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Gross Margin % Chart

Acotec Scientific Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

84.81

84.43

87.53

85.04

79.65

Acotec Scientific Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial				86.95	82.57	87.00	80.27	78.99

Competitive Comparison of Acotec Scientific Holdings's Gross Margin %

For the Medical Devices subindustry, Acotec Scientific Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acotec Scientific Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's Gross Margin % falls into.

Acotec Scientific Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Acotec Scientific Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	412.8	/	518.285
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(518.285 - 105.476)	/	518.285
	=	79.65 %

Acotec Scientific Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	199.4	/	252.428
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(252.428 - 53.033)	/	252.428
	=	78.99 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Acotec Scientific Holdings (HKSE:06669) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Acotec Scientific Holdings had a gross margin of 78.99% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Acotec Scientific Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acotec Scientific Holdings (HKSE:06669) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (HKSE:06669) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

7W3:Germany

Address

16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN

Website

http://www.acotec.cn

Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.

Executives

Vistra Trust (singapore) Pte. Limited	2301 Trustee
Nexus Partners Group Limited	2201 Interest of corporation controlled by you
Cosmic Elite Holdings Limited	2101 Beneficial owner
Li Jing	2201 Interest of corporation controlled by you
Cpechina Fund Iii, L.p.	2201 Interest of corporation controlled by you
Cpe Funds Iii Limited	2201 Interest of corporation controlled by you
Ca Medtech Investment Iii Limited	2201 Interest of corporation controlled by you
Ca Medtech Investment Ii Limited	2201 Interest of corporation controlled by you
Ca Medtech Investment (cayman) Limited	2101 Beneficial owner
Cpe Holdings Limited	2201 Interest of corporation controlled by you
Cpe Holdings International Limited	2201 Interest of corporation controlled by you
Cpe Gof Gp Limited	2201 Interest of corporation controlled by you
Cpe Global Opportunities Fund, L.p.	2201 Interest of corporation controlled by you
Boston Scientific Corporation	2201 Interest of corporation controlled by you
Cpechina Fund Iii, L. P.

Acotec Scientific Holdings (HKSE:06669) Headlines

No Headlines